CLINDACIN-P Trademark

Trademark Overview

On Thursday, July 8, 2010, a trademark application was filed for CLINDACIN-P with the United States Patent and Trademark Office. The USPTO has given the CLINDACIN-P trademark a serial number of 85080301. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, February 24, 2022. This trademark is owned by Medimetriks Pharmaceuticals, Inc.. The CLINDACIN-P trademark is filed in the Pharmaceutical Products category with the following description:

Topical pharmaceutical preparation composed in part of a dihydrogen phosphate compound for the treatment of acne; topical pharmaceutical preparation composed in part of a dihydrogen phosphate compound for use in dermatology
clindacin-p

General Information

Serial Number85080301
Word MarkCLINDACIN-P
Filing DateThursday, July 8, 2010
Status800 - REGISTERED AND RENEWED
Status DateThursday, February 24, 2022
Registration Number4039448
Registration DateTuesday, October 11, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 14, 2010

Trademark Statements

Goods and ServicesTopical pharmaceutical preparation composed in part of a dihydrogen phosphate compound for the treatment of acne; topical pharmaceutical preparation composed in part of a dihydrogen phosphate compound for use in dermatology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 12, 2010
Primary Code005
First Use Anywhere DateMonday, February 28, 2011
First Use In Commerce DateMonday, February 28, 2011

Trademark Owner History

Party NameMedimetriks Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFairfield, NJ 07004
Party NameMedimetriks Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFairfield, NJ 07004
Party NameMedimetriks Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFairfield, NJ 07004

Trademark Events

Event DateEvent Description
Thursday, February 24, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, February 24, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, February 24, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, February 24, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, October 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, October 24, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sunday, October 24, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, October 24, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 28, 2021TEAS SECTION 8 & 9 RECEIVED
Sunday, October 11, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, December 28, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, December 28, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, December 28, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 18, 2016TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 11, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, April 18, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 18, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 26, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 11, 2011REGISTERED-PRINCIPAL REGISTER
Wednesday, September 7, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 6, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, August 31, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 24, 2011STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 9, 2011USE AMENDMENT FILED
Tuesday, August 23, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 9, 2011TEAS STATEMENT OF USE RECEIVED
Friday, July 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 13, 2011EXTENSION 1 GRANTED
Wednesday, July 13, 2011EXTENSION 1 FILED
Wednesday, July 13, 2011TEAS EXTENSION RECEIVED
Tuesday, February 8, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 14, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2010PUBLISHED FOR OPPOSITION
Tuesday, November 9, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 9, 2010ASSIGNED TO LIE
Wednesday, October 27, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 26, 2010EXAMINER'S AMENDMENT ENTERED
Tuesday, October 26, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 26, 2010EXAMINERS AMENDMENT E-MAILED
Tuesday, October 26, 2010EXAMINERS AMENDMENT -WRITTEN
Monday, October 25, 2010EXAMINER'S AMENDMENT ENTERED
Monday, October 25, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 25, 2010EXAMINERS AMENDMENT E-MAILED
Monday, October 25, 2010EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 20, 2010ASSIGNED TO EXAMINER
Monday, July 12, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 12, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

clindacin topical phosphate compound part dihydrogen composed pharmaceutical preparation dermatology treatment